|
|
 | | | |
- close
- close
- close
- close
Talecris Biotherapeutics Holdings Corp. (TLCR) |
StreetInsider.com
Jun 1
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Grifols%2C+Talecris+%28TLCR%29+Receive+FTC+Acceptance+of+Consent+Agreement+in+Proposed+Acquisition/6550489.html for the full story.
BusinessWeek
Apr 11
Comment
Traders who bet on mergers are the most convinced since the offer was made in June that Grifols SA’s takeover of Talecris Biotherapeutics Holdings Corp. will be completed, giving speculators a chance for a 60 percent return.
Benzinga
Mar 7
Comment
Among the stocks that are making new 52-week highs on Monday are Genzyme (NASDAQ: GENZ), Pharmasset (NASDAQ: VRUS), Talecris Biotherapeutics (NASDAQ: TLCR) and Silicon Graphics International (NASDAQ: SGI).
GENZ shares gained 0.29% to $75.87...
StreetInsider.com
Dec 14
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Talecris+%28TLCR%29+Receives+Adverse+Ruling%2C+To+Pay+%2437M+to+Plasma+Centers+of+America/6160748.html for the full story.
StreetInsider.com
Nov 29
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/Capstone+Investments+Upgrades+Talecris+Biotherapeutics+%28TLCR%29+to+Buy%3B+Clsoing+In+On+Completion+Of+Acquisition/6130737.html for the full story.
StreetInsider.com
Oct 28
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Talecris+Biotherapeutics+%28TLCR%29+Posts+Mixed+Q3+Results+/6059287.html for the full story.
Benzinga
Oct 28
Comment
Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) today announced its financial results for the three and nine months ended September 30, 2010.
Third quarter 2010 net revenue increased by $11.3 million or 2.8% to $407.0 millio Third...
Benzinga
Oct 28
Comment
Talecris Biotherapeutics Holdings Corp. (NASDAQ: TLCR) today announced its financial results for the three and nine months ended September 30, 2010 and filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission...
StreetInsider.com
Oct 14
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Talecris+Biotherapeutics+%28TLCR%29+Receives+U.S.+FDA+Approval+for+Gamunex-C/6031999.html for the full story.
Benzinga
Oct 14
Comment
Talecris Biotherapeutics (Nasdaq: TLCR) announced today that the U.S. Food and Drug Administration approved Gamunex®-C, 10% Caprylate/Chromatography Purified) for subcutaneous administration in the treatment of primary immunodeficiency.
The...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
| |||||||
